Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106143915 | 10614391 | 5 | F | 201411 | 20160907 | 20141129 | 20160908 | EXP | CA-ROCHE-1497884 | ROCHE | 61.85 | YR | M | Y | 74.00000 | KG | 20160908 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106143915 | 10614391 | 1 | PS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Subcutaneous | 103964 | 180 | UG | SOLUTION FOR INJECTION | /wk | |||||||
| 106143915 | 10614391 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | 21511 | 1000 | MG | TABLET | ||||||||
| 106143915 | 10614391 | 3 | SS | SOVALDI | SOFOSBUVIR | 1 | Oral | 0 | 400 | MG | |||||||||
| 106143915 | 10614391 | 4 | SS | IBAVYR | RIBAVIRIN | 1 | Oral | U | 0 | 1000 | UG | QD | |||||||
| 106143915 | 10614391 | 5 | SS | PEGETRON | PEGINTERFERON ALFA-2BRIBAVIRIN | 1 | Oral | U | 0 | 1000 | MG | CAPSULE | QD | ||||||
| 106143915 | 10614391 | 6 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | Oral | 0 | 2 | MG | Q12H | ||||||||
| 106143915 | 10614391 | 7 | C | LEVOPHED | NOREPINEPHRINE BITARTRATE | 1 | Unknown | 16MCG PER MINUTE | 0 | ||||||||||
| 106143915 | 10614391 | 8 | C | VASOPRESSIN. | VASOPRESSIN | 1 | Unknown | 0.04 UNITS PER MINUTE | 0 | ||||||||||
| 106143915 | 10614391 | 9 | C | PIPERACILLIN/TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Unknown | 0 | 2.25 | G | Q8H | ||||||||
| 106143915 | 10614391 | 10 | C | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 0 | 1 | G | |||||||||
| 106143915 | 10614391 | 11 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | Intravenous (not otherwise specified) | 0 | 500 | MG | |||||||||
| 106143915 | 10614391 | 12 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | ||||||||||||
| 106143915 | 10614391 | 13 | C | HYDROMORPH CONTIN | HYDROMORPHONE | 1 | Oral | 0 | 6 | MG | CAPSULE | BID | |||||||
| 106143915 | 10614391 | 14 | C | COVERSYL | PERINDOPRIL | 1 | 0 | ||||||||||||
| 106143915 | 10614391 | 15 | C | TECTA | PANTOPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 106143915 | 10614391 | 16 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 106143915 | 10614391 | 17 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 106143915 | 10614391 | 18 | C | NOREPINEPHRINE BITARTRATE. | NOREPINEPHRINE BITARTRATE | 1 | 0 | ||||||||||||
| 106143915 | 10614391 | 19 | C | PANTOPRAZOLE MAGNESIUM | PANTOPRAZOLE MAGNESIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106143915 | 10614391 | 1 | Hepatitis C |
| 106143915 | 10614391 | 2 | Hepatitis C |
| 106143915 | 10614391 | 3 | Hepatitis C |
| 106143915 | 10614391 | 4 | Hepatitis C |
| 106143915 | 10614391 | 5 | Hepatitis C |
| 106143915 | 10614391 | 6 | Neuropathy peripheral |
| 106143915 | 10614391 | 13 | Neuropathy peripheral |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106143915 | 10614391 | LT |
| 106143915 | 10614391 | OT |
| 106143915 | 10614391 | HO |
| 106143915 | 10614391 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106143915 | 10614391 | Acute kidney injury | |
| 106143915 | 10614391 | Arthralgia | |
| 106143915 | 10614391 | Atrial fibrillation | |
| 106143915 | 10614391 | Blood glucose increased | |
| 106143915 | 10614391 | Blood pressure abnormal | |
| 106143915 | 10614391 | Chills | |
| 106143915 | 10614391 | Cough | |
| 106143915 | 10614391 | Decreased appetite | |
| 106143915 | 10614391 | Diabetes mellitus inadequate control | |
| 106143915 | 10614391 | Fatigue | |
| 106143915 | 10614391 | Feeling hot | |
| 106143915 | 10614391 | Headache | |
| 106143915 | 10614391 | Hepatic failure | |
| 106143915 | 10614391 | Insomnia | |
| 106143915 | 10614391 | Mood swings | |
| 106143915 | 10614391 | Myalgia | |
| 106143915 | 10614391 | Pain | |
| 106143915 | 10614391 | Pneumonia | |
| 106143915 | 10614391 | Septic shock | |
| 106143915 | 10614391 | Sputum discoloured | |
| 106143915 | 10614391 | Thrombocytopenia | |
| 106143915 | 10614391 | Urinary incontinence | |
| 106143915 | 10614391 | Urosepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106143915 | 10614391 | 1 | 20141010 | 201411 | 0 | |
| 106143915 | 10614391 | 2 | 20141010 | 201411 | 0 | |
| 106143915 | 10614391 | 3 | 20141010 | 2014 | 0 |